Prodromal and Early Parkinsonism Alpha-Synuclein Study

Brief description of study

The purpose of this research study is to collect samples of blood, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), skin, oral surfaces or fluids for testing of new ways to detect abnormal alpha-synuclein, a major protein involved in diseases such as Parkinson’s disease, in order to improve early diagnosis of alpha-synuclein abnormality in people with Parkinson’s disease or people at risk for Parkinson’s disease.

Clinical Study Identifier: s21-01673
Principal Investigator: Un Kang.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.